You Zhi Tong
Amministratore Delegato presso KINTOR PHARMACEUTICAL LIMITED
Patrimonio netto: 5 M $ in data 30/06/2024
Posizioni attive di You Zhi Tong
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KINTOR PHARMACEUTICAL LIMITED | Amministratore Delegato | 24/03/2009 | - |
| Presidente | 24/03/2009 | - | |
| Fondatore | 24/03/2009 | - | |
Suzhou Kintor Pharmaceuticals, Inc.
 Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China. | Amministratore Delegato | - | - |
| Presidente | - | - | |
| Fondatore | 24/03/2009 | - |
Storia della carriera di You Zhi Tong
Precedenti posizioni note di You Zhi Tong
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ANGN BIOM | Corporate Officer/Principal | - | - |
Formazione di You Zhi Tong
| Cornell University | Doctorate Degree |
| Peking University | Graduate Degree |
Statistiche
Distribuzione geografica
| Cina | 4 |
| Stati Uniti | 3 |
Posizioni
| Chief Executive Officer | 2 |
| Chairman | 2 |
| Founder | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KINTOR PHARMACEUTICAL LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Suzhou Kintor Pharmaceuticals, Inc.
Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China. | Health Technology |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Borsa valori
- Insiders
- You Zhi Tong
- Esperienza
